HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Multidrug resistance protein 3 R652G may reduce susceptibility to idiopathic infant cholestasis.

AbstractAIM:
To evaluate the role of genetic factors in the pathogenesis of idiopathic infant cholestasis.
METHODS:
We performed a case-control study, including 78 infants with idiopathic infant cholestasis and 113 healthy infants as controls. Genomic DNA was extracted from peripheral venous blood leukocytes using phenol chloroform methodology. Polymerase chain reaction was used to amplify the multidrug resistance protein 3 (MDR3) R652G fragment, and products were sequenced using the ABI 3100 Sequencer.
RESULTS:
The R652G single nucleotide polymorphism (SNP) was significantly more frequent in healthy infants (allele frequency 8.0%) than in patients (allele frequency 2.60%) (P < 0.05), odds ratio, 0.29; 95% confidence interval, 0.12-0.84. The conjugated bilirubin in patients with the AG genotype was significantly lower than in those with the AA genotype (44.70 +/- 6.15 micromol/L vs 95.52 +/- 5.93 micromol/L, P < 0.05).
CONCLUSION:
MDR3 R652G is negatively correlated with idiopathic infant cholestasis. Children with the R652G SNP in Guangxi of China may have reduced susceptibility to infant intrahepatic cholestasis.
AuthorsXiu-Qi Chen, Lin-Lin Wang, Qing-Wen Shan, Qing Tang, Shu-Jun Lian
JournalWorld journal of gastroenterology (World J Gastroenterol) Vol. 15 Issue 46 Pg. 5855-8 (Dec 14 2009) ISSN: 2219-2840 [Electronic] United States
PMID19998509 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • ATP Binding Cassette Transporter, Subfamily B
  • multidrug resistance protein 3
Topics
  • ATP Binding Cassette Transporter, Subfamily B (genetics)
  • Asian People (genetics)
  • Base Sequence
  • China
  • Cholestasis (genetics, physiopathology)
  • Disease Susceptibility
  • Gene Frequency
  • Genotype
  • Humans
  • Infant
  • Molecular Sequence Data
  • Polymorphism, Single Nucleotide
  • Sequence Analysis, DNA

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: